Abstract: Syntheses of 3-(4-arylthieno[2,3-d]pyrimidin-2-yl)-2H-chromen-2-ones 5 by the reaction of 2-iminocoumarin-3-carboxamides 1 with (2-aminothiophen-3-yl)(aryl) methanones 2 and by the alternative Suzuki coupling of 4-chlorothieno[2,3-d]pyrimidin-2-yl-2H-chromen-2-one 7 with arylboronic acids were developed. Compound 5d showed higher antimicrobial activity against Staphylococcus aureus than the reference drug streptomycin.
Introduction

4-Arylthieno
pyrimidines have been studied as adenosine receptor modulators [1] , agonists of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) receptors [2] and inhibitors of heat shock protein 90 (Hsp90) [3] . Some derivatives inhibit transforming growth factor (TGF)-β receptor kinase [4] and the IκB kinase (IKK)-β and/or tumor necrosis factor (TNF)-α receptor [5] . The effective approaches to the preparation of these compounds are the Thorpe reaction [2, 4] , cyclization of 2-amino-3-aroylthiophenes [6, 7] , arylation of thieno [2,3-d] pyrimidines by Suzuki coupling [8] or aluminum trichloride catalyzed reactions [9] . It is also known that coumarins modified at position 3 with heterocyclic fragments display antimicrobial properties [10] [11] [12] . Earlier, the 'recyclization' reactions of 2-aminobenzophenones with 2-iminocoumarin-3-carboxamides were reported as an easy one-step method for the preparation of 3-(4-arylquinazolin-2-yl)-2H-chromen-2-ones [13] as well as the preparation of 2-(2-oxo(imino)-2H-chromen-3-yl) thieno [2,3-d] pyrimidin-4(3H)-ones using the methods of 'recyclization' of 2-iminocoumarins [14] [15] [16] [17] . The reaction of 2-iminocoumarin-3-carboxamides 1 with (2-aminothiophen-3-yl)(aryl)methanones 2 has never been studied before.
Results and discussion
We studied the reaction of compounds 1 with compounds 2 as the way for synthesis of compounds 5 (Scheme 1). The previous studies showed the effectiveness of such a twostep procedure for the preparation of similar compounds [15] [16] [17] . Thus, heating a mixture of compounds 1a and 2a at 50-60°C in glacial acetic acid (method A) furnished the intermediate compound 3, albeit in a low yield and with insufficient purity. Analysis of the liquid chromatography/ mass spectrometry (LC/MS) data of the crude mixture suggested that the major product 3 was contaminated with compounds 2a (Ar = Ph), 4 and 5a.
Attempts to rearrange compounds 3 to 5 by heating in dimethylformamide (DMF) failed. The use of glacial acetic acid (8 h of boiling) for the attempted rearrangement of 3 gave traces of compound 5a. However, heating of the crude product 3 in glacial acetic acid in the presence of ammonium acetate for 3 h furnished the desired product 5a in a yield of 18%. For the synthesis of compounds 5, heating of equimolar amounts of compounds 1 and 2 in glacial acetic acid (method B) was also tried. Products 5 were isolated in yields of 61-82% after quenching the mixture with cold water followed by crystallization of the resultant precipitate from ethanol. In the third experiment (method C), product 5e was obtained by a Suzuki coupling of compound 7 with 4-methoxyphenylboronic acid, which had been prepared from the available intermediate 6 [15, 16] by treatment with POCl 3 (method C). The Suzuki reaction proceeded slowly and required 12 h for completion. The target compound 5e was isolated in a 45% yield after chromatographic purification. In comparison, method B is the most convenient way of obtaining 3-(4-arylthieno-
The antimicrobial activity of compounds 5 at a concentration of 100 μg/mL in dimethyl sulfoxide (DMSO) solution against the Staphylococcus aureus (ATCC 25923) strain was investigated using the agar well diffusion assay [18, 19] . It was found that compounds 5a-c, e show antimicrobial activity that is comparable to the activity of the reference drug streptomycin under similar conditions. However, compound 5d displays activity against the strain S. aureus that exceeds the activity of streptomycin at a concentration of 100 μg/mL.
Conclusions
New approaches to the synthesis of 3-(4-arylthieno [2,3-d] pyrimidin-2-yl)-2H-chromen-2-ones 5 were studied. It was found that 'recyclization' of 2-iminocoumarin-3-carboxamides in reaction with (2-amino-4,5,6,7-tetrahydro-1-benzothiophen-3-yl)(aryl)methanones (method B) is the most expedient synthetic route. Products 5 show antimicrobial activity against S. aureus (ATCC 25923). Compound 5d exhibits higher antimicrobial activity than the reference drug streptomycin. 
benzothieno [2,3-d] pyrimidin-4(3H)-one 6 were prepared according to the previously reported methods [15, 20, 21] . The antimicrobial activity of compounds 5 was tested using the agar well diffusion method [18, 19] . Chloro-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]  pyrimidin-2-yl)-8-methoxy-2H-chromen-2-one (7 
3-(4-
)
To 2.0 g (5.2 mmol) of 2-(8-methoxy-2-oxo-2H-chromen-3-yl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one (6) was added 10.0 mL of phosphorus oxychloride, and the mixture was stirred under reflux for 5 h. The excess of POCl 3 was distilled off and the residue was treated with ice-cold water.
3-[4-Aryl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d] pyrimidin-2-yl]-2H-chromen-2-ones (5)
Method A A mixture of 2-iminocoumarin-3-carboxamide 1a (0.3 g, 1.6 mmol), 2-amino-4,5,6,7-tetrahydro-1-benzothiophen-3-yl)(phenyl) methanone 2a (0.41 g, 1.6 mmol) and 7 mL of glacial acetic acid was stirred at 50-60°C for 3 h and then cooled. The resultant precipitate of 3 was filtered off and washed with ethanol. To 0.25 g of the crude product 3, 0.33 g (4.3 mmol) of ammonium acetate and 10 mL of glacial acetic acid were added, and the mixture was heated under reflux for 3 h. After cooling, the mixture was diluted with water and the resultant precipitate of 5 was filtered off, washed with water and dried.
Method B (general method) A mixture of 2-iminocoumarin-3-carboxamide 1 (1.6 mmol), 2-amino-4,5,6,7-tetrahydro-1-benzothiophen-3-yl)(aryl)methanone 2 (1.6 mmol) and 15 mL of glacial acetic acid was heated under reflux for 3-4 h. The product 5 precipitated after the dilution with cold water (up to 50 mL). The precipitate of compound 5 was filtered off, dried and crystallized from ethanol.
3-(4-Phenyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d] pyrimidin-2-yl)-2H-chromen-2-one (5a)
This compound was obtained in a 18% yield (method A) and a 72% yield (method B) as a yellow powder; mp 220-221°C; 1 -3-(4-phenyl-5,6,7,8-tetrahydro[1]  benzothieno[2,3-d]pyrimidin-2-yl)-2H-chromen-2-one (5b) This compound was obtained in a 68% yield (method B) as a yellow powder; mp 203-204°C; 1 (1.56 g, 11.28 mmol) and Pd(dppf)Cl 2 (0.041 g, 0.05 mmol) in a mixed solvent of 1,4-dioxane/H 2 O (40 mL, 6:1) was stirred at 90°C for 12 h. The reaction progress was monitored by thin-layer chromatography (TLC) eluting with ethyl acetate/hexanes, 1:1, and using ultraviolet (UV) detection at 365 nm. The mixture was quenched with water and extracted with chloroform (3 × 50 mL). The combined extracts were dried over Na 2 SO 4 and concentrated under reduced pressure, and the residue was subjected to silica gel chromatography eluting with CHCl 3 /MeOH (95:5-90:10). Compound 5e was obtained in a 74% yield (method B) and a 45% yield (method C) as a yellow powder; mp 236-237°C (method B); mp 237-238°C (method C); 1 
6-Chloro
